Skip to main content

Merck gets EU panel nod for first ever Ebola vaccine

A panel of the European drugs regulator on Friday recommended approving Merck & Co's vaccine for the deadly Ebola virus.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.